EcoDrugPlus

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSOPRG00000012963
Gene Symbol: DDR2
1 Cross references
265 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSOPRG00000015750
Gene Symbol: DRD2
1 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSOPRG00000014440
Gene Symbol: DRD3
1 Cross references
206 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSOPRG00000007307
Gene Symbol: DRD5
2 Cross references
186 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSOPRG00000015551
Gene Symbol: ENPP2
1 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSOPRG00000011164
Gene Symbol: EGLN1
1 Cross references
229 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSOPRG00000002831
Gene Symbol: EGLN2
1 Cross references
190 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSOPRG00000008221
Gene Symbol: EGLN3
1 Cross references
206 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSOPRG00000010205
Gene Symbol: EPAS1
1 Cross references
222 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSOPRG00000008083
Gene Symbol: ECE1
1 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSOPRG00000006002
Gene Symbol: EDNRA
1 Cross references
265 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSOPRG00000016664
Gene Symbol: EDNRB
1 Cross references
264 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).